This insights post is a summary of the blog post published by RH Strategic. View the full article at: How Women’s Health Companies Can Use PR to Drive Adoption and Trust.
Women’s health innovation, often referred to as femtech, has evolved from a niche category into one of the most significant growth opportunities in healthcare. In the U.S., women drive the majority of healthcare decisions and spending, yet women’s health remains one of the most undercapitalized areas in the system, receiving only 6% of private healthcare investment.
This gap creates structural inefficiency in how care is funded, delivered, and measured. Women’s health companies must not only compete for limited investment but also overcome education gaps before they can drive adoption. In today’s market, the challenge isn’t awareness—it’s adoption, which requires a fundamentally different approach to public relations.
The Unique PR Challenge in Women’s Health
Women’s health companies sit at the intersection of cultural stigma, clinical validation, regulatory complexity, and deeply personal experiences. As the industry moves beyond supporting specific stages in a woman’s lifecycle, innovators need to rethink how they communicate the interconnectedness of these moments.
Companies are not just marketing products; they are positioning how they fit across a patient’s care journey over time. This requires a strategic communications approach that addresses multiple stakeholders with competing priorities: patients seeking solutions, providers evaluating clinical fit, and payers assessing cost and scalability.
5 Strategies for Building Credibility and Driving Adoption
- Normalize the Conversation, But Lead It With Authority: A few years ago, simply breaking stigma was enough to stand out, especially in consumer markets. That’s changed. Today, companies gaining traction are speaking clearly and directly about health issues, centering storytelling on real patient experiences, and showing up as credible health partners—not just apps or devices.
- Focus on Education to Close the Health Literacy Gap: Awareness still lags even as investment grows. PR plays a critical role by translating complex medical information into accessible language, clearly explaining how solutions fit within a patient’s care journey, and reinforcing credibility with evidence and third-party expert validation.
- Build Trust Through Transparency and Data Privacy: Women’s health companies should make privacy, data use, and security part of the core narrative. Companies should explain data practices in plain language, monitor conversations through social listening to address concerns before they become mainstream, and treat privacy as a core product feature rather than just compliance.
- Demonstrate Value Across the Healthcare Ecosystem: Many women’s health companies hit friction when trying to move into clinical or enterprise settings. To drive adoption, companies need to clearly connect value across three distinct stakeholder groups: patients (experience and trust), providers (clinical outcomes and workflow fit), and payers (cost, scalability, and risk reduction). Strong products stall not because of lack of demand but because the story isn’t clear across stakeholders.
- Lead With Impact, Not Just Innovation: In a crowded digital health and medtech / femtech landscape, feature-driven messaging fades fast. Public relations programs should always answer the fundamental question: “What changes for women because this exists?” This reframes the narrative from product innovation to systemic impact and improved quality of life.
The Evolution of PR in Women’s Health
PR in the women’s health sector is no longer about telling stories—it’s about helping the right stakeholders understand, trust, and adopt what companies have built. This requires moving beyond awareness campaigns to strategic communications that address the specific needs and concerns of patients, providers, and payers simultaneously.
Companies that successfully navigate these complexities position themselves not as niche players but as essential partners in closing a critical gap in the U.S. healthcare system. The opportunity is significant, but success requires a PR approach as innovative as the products themselves.
To get more insights and details on this topic, read the full post at: How Women’s Health Companies Can Use PR to Drive Adoption and Trust.
